Berry Genomics Co.,Ltd

¥9.53As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000710Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (18.36%)
Div yield —
ROE (16.33%)
Diagnostics & Research
Beta (5Y) 0.50
PE TTM —
TSR TTM (27.20%)
Mkt cap ¥3.369B
ROIC (14.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥10
8.44%
84.96%
Hold 9|11|12|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.18
0.18
0.19
6.60%
11.33%
5.05%
11.06%
Revenue¥M
215.6
218.7
217.9
223.4
12.97%
9.08%
5.90%
6.51%
Peers (US$505.0M)
Cap (US$)
PE
540.0M
53.92x
500.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.402
0.120
0.120
EBIT/Intx
1.152
0.153
0.184
Own earn%
(280.85)
56.90
56.91
Sh yield%
8.35
23.94
22.71
Owners
Insiders/Inst%
0.93
38.14
Short interest%
1.58
SBC / revenue%
4.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–7
$1 testx
0.0
Incr. ROIC%
2